Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 2.650
+0.110 (4.33%)
Apr 8, 2026, 11:28 AM AEST
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 462.89 million as of April 7, 2026. Its market cap has increased by 128.72% in one year.
Market Cap
462.89M
Enterprise Value
441.95M
Revenue
3.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.65
Market Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 462.89M, an increase of 3,562.93%. That is a compound annual growth rate of 44.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 479.29M | -2.91% |
| Dec 31, 2025 | 493.64M | 110.49% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuren Pharmaceuticals | 1.52B |
| Clarity Pharmaceuticals | 1.17B |
| PYC Therapeutics | 1.10B |
| Opthea | 738.77M |
| Clinuvel Pharmaceuticals | 452.81M |
| Tetratherix | 220.32M |
| Orthocell | 218.40M |
| Starpharma Holdings | 210.07M |